New ALS Drug Approved in Canada While Still Under FDA Review

MONDAY, June 13, 2022 -- An experimental drug for amyotrophic lateral sclerosis (ALS) was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news